tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Enlivex Therapeutics Ltd

ENLV
Add to Watchlist
1.560USD
-0.020-1.27%
Market hours （ET）Quotes delayed by 15 min
24.69MMarket Cap
0.06P/E TTM

Enlivex Therapeutics Ltd

1.560
-0.020-1.27%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

ENLV Financials

See Enlivex Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Enlivex Therapeutics Ltd Earnings Date

Latest Release
Mar 25, 2026
EPS / Forecast
27.04/--
Revenue / Forecast
--/--
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
405.57
55513.80%
Analyst Rating
BUY
2026/08/16
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
73030.93%167.84
25.01%-0.09
50.57%-0.08
34.28%-0.15
52.94%-0.23
61.86%-0.12
56.66%-0.16
43.29%-0.22
-25.45%-0.49
-2.86%-0.32
---0.37
---0.39
---0.39
---0.31
----
----
----
----
----
----
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
24115.71%1.24B
15.26%-2.21M
39.66%-1.87M
16.62%-3.45M
43.09%-5.18M
56.36%-2.60M
54.42%-3.10M
42.64%-4.14M
-26.51%-9.10M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-51.79%-7.19M
-67.44%-5.73M
-218.95%-9.91M
-157.03%-8.22M
19.24%-4.74M
-61.13%-3.42M
-2.20%-3.11M
-303.02%-3.20M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
Income Statement
Revenue
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
-6.93%-5.86M
18.02%-2.56M
-3.08%-3.08M
11.29%-3.50M
10.01%-5.48M
44.58%-3.12M
55.09%-2.99M
41.77%-3.95M
22.36%-6.09M
0.86%-5.63M
-13.25%-6.65M
-5.92%-6.78M
-0.40%-7.84M
-46.92%-5.68M
-54.18%-5.87M
-68.44%-6.40M
-111.36%-7.81M
-97.24%-3.86M
-70.53%-3.81M
-100.53%-3.80M
Net Profit
24115.71%1.24B
15.26%-2.21M
39.66%-1.87M
16.62%-3.45M
43.09%-5.18M
56.36%-2.60M
54.42%-3.10M
42.64%-4.14M
-26.51%-9.10M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-51.79%-7.19M
-67.44%-5.73M
-218.95%-9.91M
-157.03%-8.22M
19.24%-4.74M
-61.13%-3.42M
-2.20%-3.11M
-303.02%-3.20M
Balance Sheet
Current assets
6606.34%1.74B
-28.08%19.50M
-25.36%21.32M
-20.19%22.65M
-23.02%25.99M
-14.86%27.11M
-7.20%28.57M
-24.49%28.38M
-35.48%33.76M
-46.24%31.84M
-52.68%30.79M
-52.61%37.58M
-39.46%52.33M
-34.39%59.23M
-29.92%65.05M
-15.44%79.30M
126.76%86.44M
185.65%90.28M
170.37%92.83M
156.19%93.78M
Total current liabilities
137.46%9.02M
8.60%3.03M
17.14%3.33M
-12.88%3.14M
-37.32%3.80M
-35.68%2.79M
-43.08%2.84M
-33.82%3.61M
-8.26%6.06M
-4.20%4.34M
18.47%4.99M
-5.05%5.45M
40.04%6.61M
-4.29%4.53M
-7.93%4.21M
17.01%5.74M
7.91%4.72M
8.18%4.73M
-8.64%4.58M
-8.02%4.91M
Total assets
8304.66%2.33B
-29.73%20.94M
-29.16%22.60M
-22.59%24.04M
-24.83%27.69M
-36.52%29.80M
-39.84%31.90M
-48.27%31.05M
-45.55%36.83M
-35.18%46.94M
-31.44%53.03M
-32.27%60.02M
-28.91%67.64M
-26.23%72.41M
-18.75%77.34M
-7.65%88.62M
135.75%95.15M
194.16%98.17M
168.61%95.19M
154.87%95.96M
Total liabilities
9466.86%392.05M
7.69%3.46M
6.11%3.54M
-18.78%3.41M
-39.26%4.10M
-60.65%3.21M
-61.58%3.34M
-55.59%4.20M
-37.53%6.75M
-10.75%8.16M
-1.83%8.69M
-13.87%9.45M
6.87%10.80M
-9.36%9.14M
77.78%8.86M
104.76%10.97M
107.49%10.11M
106.94%10.08M
-5.03%4.98M
-4.20%5.36M
Total equity
8102.76%1.93B
-34.25%17.48M
-33.29%19.05M
-23.18%20.63M
-21.59%23.59M
-31.44%26.59M
-35.58%28.56M
-46.91%26.85M
-47.07%30.08M
-38.71%38.78M
-35.26%44.34M
-34.87%50.57M
-33.16%56.84M
-28.17%63.27M
-24.08%68.49M
-14.30%77.65M
139.63%85.04M
209.07%88.08M
198.77%90.21M
182.62%90.61M
Cash Flow Statement
Net operating income
35.70%-2.63M
24.80%-1.97M
33.33%-1.20M
-2.53%-4.62M
22.61%-4.08M
51.88%-2.62M
74.41%-1.80M
22.03%-4.51M
-9.53%-5.28M
17.50%-5.44M
24.26%-7.02M
-76.93%-5.78M
26.90%-4.82M
-56.94%-6.59M
-110.27%-9.27M
-39.70%-3.27M
-14.45%-6.59M
-78.54%-4.20M
-20.03%-4.41M
-400.39%-2.34M
Net investment
-379.33%-9.38M
173.09%3.81M
234.63%1.07M
-37.76%3.17M
-18.79%3.36M
-64.59%1.40M
70.61%-794.00K
116.26%5.10M
243.78%4.13M
-91.04%3.94M
92.95%-2.70M
-152.53%-31.35M
46.20%-2.88M
207.46%44.04M
-414.03%-38.32M
200.14%59.67M
-20.43%-5.35M
427.65%14.32M
220.49%12.20M
-2822.46%-59.59M
Net financing
679.70%9.83M
40.80%352.00K
-100.00%0.00
-62.40%197.00K
--1.26M
--250.00K
10421.43%4.42M
64.78%524.00K
--0.00
-100.00%0.00
-16.00%42.00K
536.00%318.00K
100.00%0.00
-25.37%50.00K
2400.00%50.00K
-99.92%50.00K
-100.03%-3.00K
--67.00K
-97.94%2.00K
171.27%60.92M

FAQs

What are the current assets of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its current assets were 1.74B, with a year-on-year change of 6606.34.

What are the total assets of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its total assets of Enlivex Therapeutics Ltd were 2.33B, with a year-on-year change of 8304.66.

What are the total liabilities of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its total liabilities of Enlivex Therapeutics Ltd were 392.05M, with a year-on-year change of 9466.86.

What is the total equity of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its total equity of Enlivex Therapeutics Ltd was 1.93B, with a year-on-year change of 8102.76.

What is the net operating income of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its net operating income of Enlivex Therapeutics Ltd was -15.00M, with a year-on-year change of 3.45.

What is the net investment of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its net investment of Enlivex Therapeutics Ltd was -1.32M, with a year-on-year change of -114.60.

What is the net financing of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its net financing of Enlivex Therapeutics Ltd was 10.38M, with a year-on-year change of 60.85.

What is the Earnings Per Share (EPS) of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was 405.57, with a year-on-year change of 55513.80.

What is the net income of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its net income was 1.24B, with a year-on-year change of 8329.17.

What is the Return on Equity (ROE) of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its Return on Equity (ROE) was 126.17, with a year-on-year change of 325.52.

What is the Return on Assets (ROA) of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was 104.94, with a year-on-year change of 325.48.

What is the operating profit of Enlivex Therapeutics Ltd?

According to Enlivex Therapeutics Ltd's FY2025 earnings report, its operating profit was -15.00M, with a year-on-year change of 3.45.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy